Phase 2 UNITY-NHL Study Regarding Umbralisib

Apr 15, 2021 · 2m 31s
Phase 2 UNITY-NHL Study Regarding Umbralisib
Description
Owen A. O’Connor, Chief Scientific Officer at TG Therapeutics, describes the phase 2 UNITY-NHL study, the results of which led to the FDA’s approval of umbralisib.
Information
Author Peter Ciszewski, CheckRare
Organization CheckRare
Website -
Tags

Looks like you don't have any active episode

Browse Spreaker Catalogue to discover great new content

Current

Podcast Cover

Looks like you don't have any episodes in your queue

Browse Spreaker Catalogue to discover great new content

Next Up

Episode Cover Episode Cover

It's so quiet here...

Time to discover new episodes!

Discover
Your Library
Search